Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 15;213(10):1488-1498.
doi: 10.4049/jimmunol.2400119.

Tim-3 Is Required for Regulatory T Cell-Mediated Promotion of T Cell Exhaustion and Viral Persistence during Chronic Lymphocytic Choriomeningitis Virus Infection

Affiliations

Tim-3 Is Required for Regulatory T Cell-Mediated Promotion of T Cell Exhaustion and Viral Persistence during Chronic Lymphocytic Choriomeningitis Virus Infection

Hector M Nieves-Rosado et al. J Immunol. .

Abstract

Expression of T cell Ig and mucin domain-containing protein 3 (Tim-3) is upregulated on regulatory T cells (Tregs) during chronic viral infections. In several murine and human chronic infections, the expression of Tim-3 is associated with poor control of viral burden and impaired antiviral immune responses. However, the role of Tim-3+ Tregs during persistent viral infections has not been fully defined. We employed an inducible Treg-specific Tim-3 loss-of-function (Tim-3 Treg knockout) murine model to dissect the role of Tim-3 on Tregs during chronic lymphocytic choriomeningitis virus infection. Tim-3 Treg knockout mice exhibited a decrease in morbidity, a more potent virus-specific T cell response, and a significant decrease in viral burden. These mice also had a reduction in the frequency of PD-1+Tim-3+ and PD-1+Tox+ gp33-specific exhausted CD8+ T cells. Our findings demonstrate that modulation of a single surface protein on Tregs can lead to a reduction in viral burden, limit T cell exhaustion, and enhance gp33-specific T cell response. These studies may help to identify Tim-3-directed therapies for the management of persistent infections and cancer.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Tim-3+ Treg exhibit a robust immunosuppressive phenotype during chronic LCMV infection. WT splenic Treg (CD4+Foxp3+) were analyzed by flow cytometry during a 30-day LCMV Armstrong (acute) and LCMV Cl-13 infection (chronic). (A) Frequency of Tim-3+ Treg during acute and chronic LCMV infection compared to uninfected mice. (B) Proportion of Ki67+ in Tim-3 versus Tim-3+ Treg in LCMV Cl-13 at 15 days post-infection. (C) Median fluorescent intensity (MFI) of several immunosuppressive molecules in Tim-3 versus Tim-3+ Treg in LCMV Cl-13 at 15 days post-infection. (D) Levels of pSTAT3 and IL-10 in Tim-3 versus Tim-3+ Treg in LCMV Cl-13 at 15 days post-infection. (E) Levels of pSTAT5 and CD25 in Tim-3 versus Tim-3+ Treg in LCMV Cl-13 at 15 days post-infection. WT (n=6). Each dot represents a biological replicate. Graphs show mean +/− SEM. Student’s t-test analysis. P-values less than 0.05 were considered significant and included in the graphs.
Figure 2:
Figure 2:. Tim-3Treg KO mice have reduced morbidity, decreased viral burden, and increased effector T cell response late during LCMV chronic infection.
WT and Tim-3Treg KO mice were treated with tamoxifen for 5 days, followed by a 30-day LCMV Cl-13 infection. Splenic cells were analyzed at 30 days post-infection by flow cytometry. (A) Cre-induction and infection timeline. (B) Weight loss curve, WT (n=8), KO (n=8). (C) LCMV viral copies in 50 ng of total tissue RNA from liver and kidney. (D) Total splenocyte count. (E) CD8 to Treg ratio. (F) CD4+FoxP3+ Treg frequency gated on CD4+CD8 T cells. (G) Frequency of CD44hiCD62Llo effector CD8+CD4 T cells. (H) Total cell count of gp33+ CD8+ T cells. (I) Frequency of gp33+ CD8+ T cells. For C-I, WT (n=7–9), Tim-3 Treg KO (n=7–9). Graphs show mean +/− SEM. Two-way ANOVA repeated measures analysis for B, and Student’s t-test for C-I. Each in vivo experiment was performed at least twice. P-values less than 0.05 were considered significant and included in the graphs.
Figure 3:
Figure 3:. Inducible deletion of Tim-3 in Treg limits the development of Tex in gp33-specific T cells late during LCMV chronic infection.
WT and Tim-3Treg KO mice were treated with tamoxifen for 5 days, followed by a 30-day LCMV Cl-13 infection. Splenic cells were analyzed by flow cytometry at 30 days post-infection. (A) Frequency of Tim-3PD-1+ (PD-1int) and Tim-3+PD-1+ (DP, double positive) CD44hi CD8+ T cells. (B) Frequency of PD-1+Tox+ in CD44hi CD8+ T cells. (C) Frequency of PD-1int and DP gp33+ CD8+ T cells. (D) Frequency of PD-1+Tox+ in gp33+ CD8+ T cells. WT (–8), Tim-3Treg KO (n=6–8). Each dot represents an independent biological replicate. Graphs show mean +/− SEM. Student’s t-test analysis. Each in vivo experiment was performed at least twice. P-values less than 0.05 were considered significant and included in the graphs.
Figure 4.
Figure 4.. Tim-3 Treg KO mice exhibit an enhanced gp33-specific T cell response early during chronic infection:
WT and Tim-3Treg KO mice were treated with tamoxifen for 5 days, followed by an 8-day LCMV Cl-13 infection. (A) Cre-induction and infection timeline. (B) Total splenocyte count. (C) LCMV viral copies in 50 ng of total tissue RNA from liver, and kidney. (D) Total CD4+CD8 and CD4CD8+ T cell count from spleen. (E) CD4+FoxP3+Treg cell count from spleen. (F) CD8 to Treg ratio in spleen. (G) CD4+FoxP3+Treg frequency gated on CD4+CD8. (H) Frequency of CD44hiCD62Llo effector CD8+CD4 T cells. (I) Total cell count of gp33+ CD8 T cells. (J) Frequency of gp33+ CD8+CD4 T cells. (K) Expression of CD39 in total Treg. WT (n=6–8) KO (n=6–8) LCMV-infected mice. Graphs show mean +/− SEM. Student’s t-test analysis. Each in vivo experiment was performed at least twice. P-values less than 0.05 were considered significant and included in the graphs.
Figure 5.
Figure 5.. Inducible Treg-specific Tim-3 deletion limits the development of Tex in gp33-specific T cells early during chronic infection:
WT and Tim-3Treg KO mice were treated with tamoxifen for 5 days, followed by 8-day LCMV Cl-13 infection for (A-D). Similarly, WT and Tim-3Treg KO mice for E-F received adoptively transferred WT P14 T cells before infection. For all experiments, splenic cells were analyzed by flow cytometry at 8 days post-infection. (A) Frequency of Tim-3PD-1+ (PD-1int) and Tim-3+PD-1+ (DP-“double positive”) CD44hi CD8+ T cells. (B) Frequency of PD-1+Tox+ in CD44hi CD8+ T cells. (C) Frequency of PD-1int and DP gp33+ CD8+ T cells. (D) Frequency of PD-1+Tox+ in gp33-specific CD8+ T cells. (E) Frequencies of PD-1int and DP in adoptively transferred WT P14 T cells. (F) Frequency of Tox+ gated on adoptively transferred WT P14 T cells. WT (–8), KO (n=6–8). Each dot represents an independent biological replicate. Graphs show mean +/− SEM, based on Student’s t-test. Each in vivo experiment was performed at least twice. P-values less than 0.05 were considered significant and included in the graphs.
Figure 6.
Figure 6.. Tim-3 on Treg limits T cell function in gp33-specific T cells early during chronic infection.
WT and Tim-3Treg KO mice were treated with tamoxifen for 5 days, followed by LCMV Cl-13 infection (A-D). For E-F, WT and Tim-3Treg KO mice received adoptively transferred WT P14 T cells before infection. For all experiments cells were analyzed by flow cytometry at 8 days post-infection. (A) Light microscopy images displaying cell killing of B16.gp33 target cells by CD44hiCD8+ T cells at a 3:1 effector:target ratio. (B) Cytolysis of B16.gp33 cells during 25 hr incubation. (C-D) Frequency of TNF+ and IFNγ+ (C) and Gzmb expression (D) in gp33+ CD8+ T cells after in vitro gp33 peptide simulation for 5 hours. (E) Frequency of TNF+ and IFNγ+ in adoptively transferred WT P14. (F) Gzmb expression in adoptively transferred WT P14. Single-cell suspensions were stimulated in vitro with gp33 peptide. WT (–8), KO (n=6–8). Each dot represents an independent biological replicate. Graphs show mean +/− SEM. Student’s t-test. Each in vivo experiment was performed at least twice. P-values less than 0.05 were considered significant and included in the graphs.
Figure 7:
Figure 7:. Treg-specific Tim-3 deletion alters the transcriptional profile of specific major WT P14 Tex subsets early during chronic infection.
WT and Tim-3Treg KO mice were treated with tamoxifen for 5 days, followed by adoptive transfer of WT P14 and an 8-day LCMV Cl-13 infection. Splenic lymphocytes were analyzed by flow cytometry at 8 days post-infection. (A) Experimental timeline and the specific P14 Tex subsets that were FACS-sorted for bulk-RNA seq analysis. P14 Tex subsets sequenced, PD-1Tim-3 (DN “double negative”), PD-1+Tim-3 (PD-1int), and PD-1+Tim-3+ (DP “double positive”). (B) Principal component analysis for Tex subsets from WT and Tim-3Treg KO mice. (C) Heatmap of selected significantly differentiated genes (p-value <0.05, and p-adjusted <0.02) in DN, PD-1int, and DP. WT (n=3), KO (n=3). For (B), each dot represents a biological replicate.

References

    1. Penaloza-MacMaster P, Kamphorst AO, Wieland A, Araki K, Iyer SS, West EE, O’Mara L, Yang S, Konieczny BT, Sharpe AH, Freeman GJ, Rudensky AY, and Ahmed R. 2014. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med 211: 1905–1918. - PMC - PubMed
    1. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, and Nelson DR. 2004. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062–1071. - PubMed
    1. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, and Janssen HL. 2005. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41: 771–778. - PubMed
    1. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, and Chang KM. 2003. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38: 1437–1448. - PubMed
    1. Eggena MP, Barugahare B, Jones N, Okello M, Mutalya S, Kityo C, Mugyenyi P, and Cao H. 2005. Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation1. The Journal of Immunology 174: 4407–4414. - PubMed

MeSH terms

Substances